My research focuses on improving tissue microarray technology and the preservation of the tissue once on a TMA slide.
- Long-term preservation of antigenicity on tissue microarrays. Kyle A DiVito, Lori A Charette, David L Rimm, Robert L Camp Department of Pathology, Yale University, New Haven, CT, USA. Laboratory Investigation (Impact Factor: 3.96). 09/2004; 84(8):1071-8. DOI:10.1038/labinvest.3700131
- Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray. Gina G Chung, Harry H Yoon, Maciej P Zerkowski, Sriparna Ghosh, Laurie Thomas, Malini Harigopal, Lori A Charette, Ronald R Salem, Robert L Camp, David L Rimm, Barbara A Burtness [more] Yale Cancer Center and Department of Internal Medicine, Section of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut 06520, USA. Cancer (Impact Factor: 5.2). 05/2006; 106(8):1677-84. DOI:10.1002/cncr.21783
- Construction and validation of tissue microarrays of ductal carcinoma in situ and terminal duct lobular units associated with invasive breast carcinoma. Xiaohong Rose Yang, Lori A Charette, Montserrat Garcia-Closas, Jolanta Lissowska, Edina Paal, Mary Sidawy, Stephen M Hewitt, David L Rimm, Mark E Sherman [more] Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD 20852, USA. Diagnostic Molecular Pathology (Impact Factor: 1.86). 10/2006; 15(3):157-61. DOI:10.1097/01.pdm.0000213453.45398.e0